Home / Brands / Generic Peptides / Generic Peptides Semaglutide 2 to 10 mg GLP-1 Research Vials
Generic Peptides Semaglutide 2 to 10 mg GLP-1 Research Vials
Generic Peptides Semaglutide 2 to 10 mg GLP-1 Research Vials
Generic Peptides Semaglutide 2 to 10 mg GLP-1 Research Vials
Generic Peptides

Generic Peptides Semaglutide 2 to 10 mg GLP-1 Research Vials

Injection · 2 mg · vial

Out of stock
$45.00

Generic Peptides Semaglutide is a GLP-1 receptor agonist peptide, a lyophilized powder supplied for laboratory research in three vial sizes: 2 mg, 5 mg and 10 mg.

GMP-manufactured, each batch is HPLC-verified with the Certificate of Analysis on file. Semaglutide for sale with U.S. domestic and international shipping and fast dispatch within two business days after payment.

Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Generic Peptides Semaglutide - 2 to 10 mg GLP-1 Vials

Generic Peptides Semaglutide is a GLP-1 receptor agonist peptide supplied as a lyophilized research powder in 2 mg, 5 mg and 10 mg vials. A chain that binds it to albumin is where its long action comes from; the Tirzepatide and Retatrutide vials cover the dual and other incretin forms.

  • Three vial sizes - 2, 5 and 10 mg
  • GLP-1 receptor agonist peptide
  • Lyophilized powder - needs a solvent
  • GMP-made, HPLC-verified, COA

Variant Comparison

Same peptide at three strengths.

Variant Dosage Form and quantity Best use
Semaglutide 2 mg 2 mg Vial Short
Semaglutide 5 mg 5 mg Vial Standard
Semaglutide 10 mg 10 mg Vial Extended

The 10 mg vial carries about five times the material of the 2 mg vial and is the size with a U.S. domestic option. Fat work uses a lipolytic fragment such as AOD 9604 in a separate group.

How Semaglutide Works

The peptide binds the GLP-1 receptor and mimics the gut hormone that signals fullness and drives glucose-dependent insulin release. The licensed drug adds a fatty di-acid side chain that binds albumin and a position 8 change that blocks DPP-4, which stretch a hormone that lasts minutes into one that lasts about a week.

Reconstitution & Storage

Dissolve the powder with sterile or bacteriostatic water, which is not part of the pack, letting the water run down the vial wall and swirling rather than shaking. Divide the milligrams on the vial by the millilitres added to read mg per mL. Keep the powder at 2-8 C or -20 C and the mixed solution at 2-8 C for about four weeks.

Dosage & Administration

This vial is not a medicine and no dose is offered here. Licensed semaglutide products are given once weekly by subcutaneous injection under a physician with a step-up schedule, and they carry a boxed warning about thyroid C-cell tumours seen in rodents.

Supplied for laboratory research only, not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before use.

Specifications

Trade NameSemaglutide
Generic NameSemaglutide (GLP-1 agonist)
ManufacturerGeneric Peptides
Dosage2 mg, 5 mg or 10 mg per vial
PackageLyophilized powder, one vial
Drug ClassIncretin peptide; GLP-1 agonist
AdministrationSubcutaneous (research protocols)
StorageLyophilized 2-8 C or -20 C; mixed 2-8 C, 4 weeks
Prescription StatusResearch use only
VerificationBatch details confirmed with supplier
ShippingInternational about USD 35; USA option on 10 mg

Stacks

Incretin Comparison Arm

Semaglutide as the single GLP-1 arm and Tirzepatide as the dual agonist arm, kept in separate groups so receptor profile stays the only variable.

Expected outcome: a model that compares one incretin receptor with two on the same appetite read-outs.

Triple Agonist Arm

Semaglutide beside Retatrutide and a Kalpa comparator, Kalpa Mounjarixyl 5 mg, as three separate arms.

Expected outcome: a side by side look at how GIP and glucagon activity changes the metabolic signal.

Lipolytic Read-Out

Semaglutide in the incretin arm and HGH Frag 176-191 in the fat-mobilisation arm, sampled on separate days.

Expected outcome: a study that separates appetite-driven intake from a lipolytic fragment in one model.

For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.

FAQ

Before you ask

Questions, answered

It is a peptide agonist of the GLP-1 receptor, a modified version of the gut hormone glucagon-like peptide-1. Two changes define it: a fatty di-acid chain that binds the molecule to albumin for slow release, and a substitution at position 8 that blocks the DPP-4 enzyme. The FDA label gives its formula as C187H291N45O59 and its mass as 4113.58 g/mol.

No. The products listed here are lyophilized research material sold for laboratory work only. The licensed medicines built on semaglutide are prescription injections given once weekly under medical supervision, with a titration schedule, monitoring and a boxed warning. Nothing on this page is a suggested human dose.

Keep the sealed powder cold, dry and dark, at 2-8 C or -20 C for long storage, and let it reach room temperature before opening, because peptides absorb moisture. Dissolve it with sterile or bacteriostatic water down the vial wall and swirl. The solution keeps at 2-8 C for about four weeks and is never frozen.

In the FDA label the most common reactions are nausea, diarrhoea, vomiting, constipation and abdominal pain, with headache, fatigue and dyspepsia also reported. Serious risks on the label include pancreatitis, gallbladder disease, hypoglycaemia with insulin, kidney injury from dehydration, and thyroid C-cell tumours in rodents.

The label contraindicates it in anyone with a personal or family history of medullary thyroid carcinoma or with multiple endocrine neoplasia syndrome type 2, and in anyone with a prior serious hypersensitivity reaction to the peptide. This material is not for human or veterinary use and is not a treatment for any condition.

It is not on the WADA Prohibited List. WADA added semaglutide to its Monitoring Program in 2024 and has said the status of GLP-1 receptor agonists, including semaglutide and tirzepatide, stays unchanged for 2027. Monitoring means labs report findings for study rather than as a doping violation.

All three vial sizes are listed on this page as research material with checkout for international and U.S. domestic shipping. Shipping is about 35 dollars internationally and 25 dollars domestically, orders are handled in one to two days, and delivery takes four to ten days abroad and up to five days inside the United States.

No reviews yet

Be the first to share your experience with Generic Peptides Semaglutide 2 to 10 mg GLP-1 Research Vials

Log in to write a review

Complete the cycle

Stack it with

View all